| |
| |
|
| Insider
Information: |
Phillips Barclay A |
| Relationship: |
|
| City: |
Carlsbad |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
38,669 |
|
|
Indirect Shares
|
308,801 |
|
|
| Direct
Value |
$13,902 |
|
|
|
Indirect Value
|
$155,018 |
|
|
| Total
Shares |
347,470 |
|
|
| Total
Value |
$168,920 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Acorda Therapeutics Inc |
ACOR |
Director |
2006-02-15 |
0 |
2008-06-13 |
308,801 |
Premium* |
|
|
Novavax Inc |
NVAX |
SVP, Chief Financial O... |
2017-07-31 |
38,669 |
2013-06-12 |
0 |
Premium* |
|
|
G1 Therapeutics Inc |
GTHX |
|
2018-11-15 |
0 |
2018-11-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
20 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GTHX |
G1 Therapeutics Inc |
SVP & Chief Financial Officer |
• – – |
2018-11-15 |
4 |
AS |
$39.92 |
$199,591 |
D/D |
(5,000) |
0 |
0 |
- |
|
| GTHX |
G1 Therapeutics Inc |
SVP & Chief Financial Officer |
• – – |
2018-11-15 |
4 |
OE |
$19.46 |
$97,300 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| NVAX |
Novavax Inc |
SVP, Chief Financial Officer |
• – – |
2017-07-31 |
4 |
B |
$0.89 |
$1,831 |
D/D |
2,057 |
38,669 |
2.66 |
- |
|
| NVAX |
Novavax Inc |
SVP, Chief Financial Officer |
• – – |
2017-05-11 |
4 |
B |
$0.84 |
$20,950 |
D/D |
25,000 |
36,612 |
2.74 |
- |
|
| NVAX |
Novavax Inc |
SVP, Chief Financial Officer |
• – – |
2017-01-31 |
4 |
B |
$1.12 |
$1,829 |
D/D |
1,633 |
11,612 |
2.66 |
- |
|
| NVAX |
Novavax Inc |
SVP, Chief Financial Officer |
• – – |
2016-07-31 |
4 |
B |
$4.29 |
$1,810 |
D/D |
422 |
9,979 |
2.66 |
- |
|
| NVAX |
Novavax Inc |
SVP, Chief Financial Officer |
• – – |
2016-01-31 |
4 |
B |
$4.38 |
$1,774 |
D/D |
405 |
9,557 |
2.66 |
- |
|
| NVAX |
Novavax Inc |
SVP, Chief Financial Officer |
• – – |
2015-08-20 |
4 |
S |
$12.81 |
$128,122 |
D/D |
(10,000) |
9,152 |
0 |
- |
|
| NVAX |
Novavax Inc |
SVP, Chief Financial Officer |
• – – |
2015-08-19 |
4 |
S |
$13.20 |
$246,201 |
D/D |
(18,656) |
19,152 |
0 |
- |
|
| NVAX |
Novavax Inc |
SVP, Chief Financial Officer |
• – – |
2015-07-31 |
4 |
B |
$2.28 |
$1,742 |
D/D |
764 |
37,808 |
2.66 |
- |
|
| NVAX |
Novavax Inc |
SVP, Chief Financial Officer |
• – – |
2015-01-31 |
4 |
B |
$2.28 |
$19,125 |
D/D |
8,388 |
37,044 |
2.74 |
- |
|
| NVAX |
Novavax Inc |
SVP, Chief Financial Officer |
• – – |
2014-10-03 |
4 |
B |
$4.11 |
$20,550 |
D/D |
5,000 |
28,656 |
2.74 |
- |
|
| NVAX |
Novavax Inc |
SVP, Chief Financial Officer |
• – – |
2014-07-31 |
4 |
B |
$2.28 |
$20,037 |
D/D |
8,788 |
23,656 |
2.74 |
- |
|
| NVAX |
Novavax Inc |
SVP, Chief Financial Officer |
• – – |
2014-03-25 |
4/A |
B |
$4.25 |
$21,225 |
D/D |
5,000 |
14,868 |
2.74 |
- |
|
| NVAX |
Novavax Inc |
SVP, Chief Financial Officer |
• – – |
2014-03-25 |
4 |
S |
$4.25 |
$21,225 |
D/D |
(5,000) |
14,868 |
0 |
- |
|
| NVAX |
Novavax Inc |
SVP, Chief Financial Officer |
• – – |
2014-01-31 |
4 |
B |
$2.29 |
$22,598 |
D/D |
9,868 |
9,868 |
2.74 |
- |
|
| NVAX |
Novavax Inc |
SVP, Chief Financial Officer |
• – – |
2013-06-12 |
4/A |
B |
$0.00 |
$0 |
D/D |
0 |
0 |
2.66 |
- |
|
| NVAX |
Novavax Inc |
Director |
– • – |
2013-06-12 |
4 |
B |
$1.90 |
$95,000 |
D/D |
50,000 |
200,000 |
2.39 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Director |
– • – |
2008-06-13 |
4 |
S |
$30.20 |
$7,120,079 |
I/I |
(235,000) |
308,801 |
0 |
- |
|
| ACOR |
Acorda Therapeutics Inc |
Director |
– • – |
2006-02-15 |
4 |
A |
$0.00 |
$0 |
I/I |
543,801 |
543,801 |
|
- |
|
20 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
